Similarly, mRNA for mutated form of IDH1/2 gene and mRNA for abnormal C-myc gene were observed in EVs circulating in blood of glioma and medulloblastoma patients, respectively (Balaj et al., 2011; Chen et al., 2013). This evidence concerns the gene MYC and central nervous system cancer.